Prevention & care

H. pylori: stomach infection, ulcers, cancer risk, testing, eradication, and follow-up

8 sources · Latest source check 2026-10-08 UTC

On this page

Helicobacter pylori is a bacterium living in stomach mucus. Persistent infection can inflame the lining and contribute to ulcers or selected cancers. An infection test does not itself establish those separate diagnoses.[1]

Four labels describe different findings

Four labels describe different findings
Label	Meaning
H. pylori infection	The bacterium is present; not a complete ulcer or cancer diagnosis.[1]
Gastritis	Inflammation of the stomach lining.[1]
Peptic ulcer	An open sore in stomach or duodenal lining.[3]
Gastric cancer / MALT lymphoma	Different cancer families linked to infection.[1]

The bacterium changes its immediate environment

NCI explains that H. pylori can locally neutralize acid and attach within stomach mucus. That mechanism does not mean the entire stomach is acid-free or that infection can be inferred from “low stomach acid” symptoms. A plausible mechanism and a clinically established infection remain different kinds of information.[1]

Acquisition often occurs in childhood

NCI describes person-to-person routes involving stool, saliva or vomit; crowding and sanitation affect risk. A household association does not identify who transmitted it. Testing needs the actual context rather than blame.[1]

Infection, tissue injury and cancer need separate evidence

NCI links infection to gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma. These are different cancers. A risk factor does not establish an existing tumor; eradication, lesion investigation and cancer treatment have different purposes.[1]

Breath and stool tests look for evidence of current infection

NIDDK describes a urea breath test that detects labeled carbon dioxide produced when the bacterium processes urea, and stool testing for infection. These test results answer a different question from whether an ulcer, bleeding source or tissue abnormality is present.[2]

A positive antibody result can reflect past infection

MedlinePlus explains that antibody tests cannot reliably distinguish current from previous infection. The presence of antibodies is therefore not a stand-alone demonstration of current infection or proof that eradication failed. Ask which test was used and whether it answers the intended question.[3]

Medicines and timing can affect interpretation

MedlinePlus describes preparation involving selected medicines. Tell the team about acid-suppressing drugs, antibiotics and other treatments, and obtain the test-specific instructions. Do not stop prescribed medication independently; a negative test obtained in unsuitable conditions may need reassessment.[3]

Looking at the lining and testing infection are not interchangeable

NIDDK describes endoscopy and tissue samples to identify an ulcer, clarify its cause or assess other abnormalities. An infection test does not visualize the lining. Conversely, seeing a lesion does not supply every pathology or bacterial finding. The reason for each investigation should be explicit.[2]

Eradication uses a coordinated combination of medicines

NIDDK describes antibiotics with acid suppression and sometimes bismuth. Killing the bacterium, allowing an ulcer to heal and relieving pain are related but distinct aims. A symptom response to an acid medicine is not a substitute for an appropriate infection test or a completed eradication assessment.[4]

An old familiar antibiotic combination may no longer be appropriate

The ACG’s 2024 explanation emphasizes increasing resistance and the need for susceptibility evidence before selected clarithromycin-based treatment. Prior antibiotic exposure, allergy, previous attempts, access and local patterns matter. A medicine name copied from a video or older guideline is not enough to choose a regimen.[7]

Adherence and adverse effects need a workable plan

NIDDK explains why completing the prescribed course matters. Tell the care team about adverse effects, missed doses and practical barriers so they can respond safely. This page supplies no antibiotic dose, substitute or self-directed repeat course; a previous failed course needs reassessment.[4]

Feeling better does not prove the bacterium is gone

The 2024 ACG guidance requires a post-treatment test of cure. Its explanation specifies an interval after antibiotics and preparation around acid suppression to avoid misleading results. Arrange the timing with the team. Symptom improvement, treatment completion and documented eradication are three different outcomes.[7]

Newer guidance includes selected higher-risk and household contexts

The ACG explanation expands testing discussion to selected gastric-risk conditions and household members of infected adults. That is a scoped clinical framework, not indiscriminate screening without a plan to act on results. Age, prior treatment and local guideline differences still need attention.[7]

Population screen-and-treat has its own implementation questions

IARC’s April 2025 announcement describes global guidance covering need, readiness, test choice, treatment, antibiotic stewardship, quality, costs and equity. Only the announcement and report scope were inspected here, not a full independent appraisal of all chapters. It cannot establish that a commercial home-test program has equivalent outcomes.[8]

A special ulcer diet is not established eradication treatment

NIDDK’s September 2022 nutrition explanation does not recommend a special diet to prevent or treat peptic ulcers. Food tolerance and adequate nutrition are different goals from killing H. pylori. A diet testimonial alone cannot establish bacterial clearance; detailed probiotic-adjunct evidence is not independently appraised in this page.[5]

Bleeding or severe pain needs prompt assessment

MedlinePlus advises immediate medical help for black, tarry stool, blood in vomit, severe persistent abdominal pain or dizziness/fainting. Do not wait for a routine infection test to investigate possible ulcer complications.[3]

Evidence & uncertainty

Testing and treatment need a purpose and population. The 2024 North American guideline emphasizes confirming eradication and accounting for resistance. IARC’s 2025 population-prevention report also addresses program readiness, harms, stewardship and equity. These settings cannot be reduced to one instruction that every person worldwide should buy a test or take the same antibiotics.[6][8]

Selected-source overview · Independent review pending

Published questions

Is H. pylori a worm or other parasite?

Selected-source overview · Independent review pending. Read the evidence context.

It is a bacterium.[1]

Evidence behind this answer

Helicobacter pylori and Cancer
agency condition or prevention explanation · Date not stated
Selected relevant original official page passages inspected · Local stomach environment, transmission and distinct disease risks